Tuesday, December 7, 2010

E4: Dose-Response Information to Support Drug Registration




The tripartite harmonised ICH guideline was finalised (Step 4) in March 1994. This document gives recommendations on the design and conduct of studies to assess the relationship between doses, blood levels and clinical response throughout the clinical development of a new drug.

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...
Subscribe to Quality Assurance and GMP by Email